White label ELPA - ClinicalTrials.eu

Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers

Not recruiting

2 1 1
Investigated diseases:
- Basal cell carcinoma
- Skin cancer
Investigated drugs:
- Balstilimab
Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy

Not recruiting

3 1 1
Investigated diseases:
- Hypertrophic cardiomyopathy
Investigated drugs:
- Empagliflozin
Study of Atezolizumab treatment in patients with metastatic bladder cancer (urothelial cancer) after radical cystectomy

Not recruiting

3 1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
- Atezolizumab
Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- Ro7790121
+10
Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

Not recruiting

3 1
Investigated diseases:
- Colitis ulcerative
+10
Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

Not recruiting

2 1
Investigated diseases:
- Narcolepsy
Investigated drugs:
- Alks 2680
Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis

Not recruiting

3 1 1
Investigated diseases:
- Axial spondyloarthritis
Investigated drugs:
- Bimekizumab
+1
Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated drugs:
- Atezolizumab
+2
Study on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines

3 1 1
Investigated diseases:
- Chronic spontaneous urticaria
Investigated drugs:
- Corticosteroids For Systemic Use, Plain
- Remibrutinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies